- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: cidp.
Displaying page 1 of 1.
EudraCT Number: 2017-002511-34 | Sponsor Protocol Number: V1.0.14062017 | Start Date*: 2018-09-26 |
Sponsor Name:Academisch Medisch Centrum | ||
Full Title: Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in CIDP (OPTIC trial) | ||
Medical condition: Chronic inflammatory demyelinating polyneuropathy (CIDP) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002411-17 | Sponsor Protocol Number: CIDP01 | Start Date*: 2019-04-29 | |||||||||||
Sponsor Name:UCB Biopharma SRL | |||||||||||||
Full Title: A Multicenter, Randomized, Subject-Blind, Investigator-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Rozanolixizumab in Subjects with Chronic ... | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DK (Completed) NL (Completed) DE (Completed) ES (Completed) FR (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004392-12 | Sponsor Protocol Number: CIDP04 | Start Date*: 2019-11-20 | |||||||||||
Sponsor Name:UCB Biopharma SPRL | |||||||||||||
Full Title: An Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) FR (Completed) BE (Completed) ES (Restarted) NL (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005496-87 | Sponsor Protocol Number: 161403 | Start Date*: 2015-10-15 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human... | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyradiculoneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DK (Completed) DE (Completed) SE (Completed) GB (GB - no longer in EU/EEA) ES (Completed) NO (Completed) SK (Completed) GR (Completed) AT (Completed) PL (Completed) HR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000374-37 | Sponsor Protocol Number: 161505 | Start Date*: 2016-10-28 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculone... | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyradiculoneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DK (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) NO (Ongoing) GR (Ongoing) SK (Prematurely Ended) DE (Completed) PL (Completed) HR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003076-39 | Sponsor Protocol Number: ARGX-113-1802 | Start Date*: 2020-06-25 | |||||||||||
Sponsor Name:argenx BVBA | |||||||||||||
Full Title: A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | |||||||||||||
Medical condition: Chronic Inflammatory Demyelinating Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) HU (Completed) ES (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) BE (Completed) NL (Completed) BG (Completed) DK (Completed) AT (Completed) IT (Ongoing) RO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003107-35 | Sponsor Protocol Number: ARGX-113-1902 | Start Date*: 2020-07-15 | |||||||||||
Sponsor Name:argenx BVBA | |||||||||||||
Full Title: Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Chronic Inflammatory Demyelinating Polyneuro... | |||||||||||||
Medical condition: Chronic Inflammatory Demyelinating Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) CZ (Completed) BE (Trial now transitioned) HU (Ongoing) PL (Trial now transitioned) GB (GB - no longer in EU/EEA) NL (Trial now transitioned) BG (Trial now transitioned) DK (Trial now transitioned) AT (Trial now transitioned) FR (Trial now transitioned) IT (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.